Autoantibodies and Clinical Symptoms in Infective Endocarditis Patients

Tel-Aviv Sourasky Medical Center100 enrolled

Overview

The purpose is to evaluate autoantibodies in infective endocarditis patients before, at the beginning of treatment, and after the end of the treatment, and to correlate the autoantibodies in the presence of clinical symptoms.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Infective Endocarditis

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Infective endocarditis patients by DUKES criteria Exclusion Criteria: * HIV positive * Patients suffering from other infective diseases other than endocarditis. * Patient suffering from collagen diseases for example: systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), mixed connective tissue disease, and scleroderma.

Locations (1)

Sourasky Medical Center

Tel Aviv, Israel

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.